The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
DLH HLDGS CORP COM 23335Q100 94 47,999 SH   OTR   47,999 0 0
ECHO THERAPEUTICS INC COM NEW 27876L906 804 377,633 SH   OTR   377,633 0 0
INSPIREMD INC COM NEW 45779A309 8 24,453 SH   OTR   24,453 0 0
NAVIDEA BIOPHARMACEUTICALS I COM 63937X103 18,213 11,454,831 SH   OTR   11,454,831 0 0
PEDEVCO CORP COM NEW 70532Y204 28 34,444 SH   OTR   34,444 0 0
VIRCO MFG CO COM 927651109 185 68,179 SH   OTR   68,179 0 0